Clinical Trial Update: Lenalidomide (Revlimid) in Chronic Lymphocytic Leukemia (CLL) [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial of lenalidomide (Revlimid) in chronic lymphocytic leukemia, with the study completed and results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Leukemia

Drugs mentioned

• Lenalidomide (Revlimid) (lenalidomide)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Chronic Lymphocytic Leukemia, Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2011-04-21